- Home
- IMRX vs PROP Comparison
IMRX vs PROP Comparison
Compare IMRX & PROP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMRX
- PROP
- Stock Information
- Founded
- IMRX 2008
- PROP 2001
- Country
- IMRX United States
- PROP United States
- Employees
- IMRX 54
- PROP N/A
- Industry
- IMRX Biotechnology: Pharmaceutical Preparations
- PROP Investment Bankers/Brokers/Service
- Sector
- IMRX Health Care
- PROP Finance
- Exchange
- IMRX Nasdaq
- PROP Nasdaq
- Market Cap
- IMRX 145.7M
- PROP 168.7M
- IPO Year
- IMRX 2021
- PROP N/A
- Fundamental
- Price
- IMRX $4.24
- PROP $3.46
- Analyst Decision
- IMRX Strong Buy
- PROP Strong Buy
- Analyst Count
- IMRX 4
- PROP 5
- Target Price
- IMRX $13.25
- PROP $8.75
- AVG Volume (30 Days)
- IMRX 3.1M
- PROP 1.2M
- Earning Date
- IMRX 08-05-2025
- PROP 08-15-2025
- Dividend Yield
- IMRX N/A
- PROP N/A
- EPS Growth
- IMRX N/A
- PROP N/A
- EPS
- IMRX N/A
- PROP N/A
- Revenue
- IMRX N/A
- PROP $21,529,000.00
- Revenue This Year
- IMRX N/A
- PROP $5,974.95
- Revenue Next Year
- IMRX N/A
- PROP $26.36
- P/E Ratio
- IMRX N/A
- PROP N/A
- Revenue Growth
- IMRX N/A
- PROP N/A
- 52 Week Low
- IMRX $1.00
- PROP $2.74
- 52 Week High
- IMRX $4.60
- PROP $12.30
- Technical
- Relative Strength Index (RSI)
- IMRX 77.22
- PROP 46.06
- Support Level
- IMRX $3.31
- PROP $3.30
- Resistance Level
- IMRX $4.60
- PROP $3.72
- Average True Range (ATR)
- IMRX 0.43
- PROP 0.27
- MACD
- IMRX 0.12
- PROP 0.03
- Stochastic Oscillator
- IMRX 96.10
- PROP 56.30
About IMRX Immuneering Corporation
Immuneering Corp is a biopharmaceutical company. It is focused on improving patient outcomes across a spectrum of debilitating oncologic and neurologic diseases by applying deep knowledge of translational bioinformatics to every stage of the drug development process. The company's proprietary computational Disease Cancelling Technology platform enables Immuneering's drug discovery programs. The company also provides unparalleled computational biology capabilities to pharmaceutical and biotechnology companies.
About PROP Prairie Operating Co.
Prairie Operating Co is a Houston-based independent energy company engaged in the development and acquisition of oil and natural gas resources in the United States. The Company's assets and operations are concentrated in the oil and liquids-rich regions of the Denver-Julesburg (DJ) Basin, with a focus on the Niobrara and Codell formations. The Company is committed to the responsible development of its oil and natural gas resources and is focused on maximizing returns through consistent growth, capital discipline, and sustainable cash flow generation.